Oriza-backed Chinese Biotechnology Firm Ascentage Pharma Files For Hong Kong IPO

Suzhou-based biopharmaceutical company Ascentage Pharma Group International has filed for an initial public offering in Hong Kong, according to its IPO prospectus.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in